Newsroom | 12501 results

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that its Freedom60® Infusion Pump, including adapter for use with 50 mL prefilled syringes, has achieved certification under the European Union Medical Devices Regulation (EU MDR 2017/745), ena...

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. The Company also initiated guidance for the full year 2026. Recent Highlights Fourth quarter 2025 net revenues gre...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S....

LOUISVILLE, Ky.--(BUSINESS WIRE)--A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP)—conducted by a Humana Healthcare Research team and Dr. Joseph S. Ross of the Yale School of Medicine—reveals a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with type 2 diabetes from 2021 to 2023. The study also compared the demographic and clinical characteristics of members with type 2 diabetes who used...

DALLAS--(BUSINESS WIRE)--o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, is now live globally with Demand Planning and Supply Planning on the o9 platform. This deployment supports Teleflex’s multi-year effort to enhance its end-to-end integrated business planning and supply chain management capabilities. With Demand Planning and Supply...

东京--(BUSINESS WIRE)--(美国商业资讯)-- 山下株式会社（总部：日本静冈县岛田市，法人代表：山下和洋，以下简称"山下"），主营康复辅助器具租赁及布草供应业务。其负责中国业务统筹的子公司山下（上海）养老服务有限公司（法人代表：永井新，注册地：中国上海）为响应四川省民政厅推出的《四川省康复辅助器具社区租赁服务试点工作方案》，在四川成都设立"山下福至（成都）健康管理有限公司"，并于2025年11月起在省民政厅和各市民政及相关部门的支持下，正式推行面向老年人的康复辅助器具社区租赁的服务。此外，2025年12月底公司在成都设立康复辅助器具租赁、居家适老化改造、康养产品销售为“三位一体”的体验式展厅，进一步扩大服务及市场开拓力度。 此前，山下集团在中国的业务主要聚焦在上海和天津等东北沿海地区。此次进入四川，标志着公司业务版图正式拓展至中国西南腹地。 ■什么是《四川省康复辅助器具社区租赁服务试点工作方案》？ 伴随少子化与老龄化在中国加速演进，推动居家养老已成为迫切的社会需求。在此背景下，四川省民政厅于2025年3月20日发布了《四川省康复辅助器具社区租赁服务试点工作方案》，计划在...

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, has reached an agreement with BeauBrain Healthcare that brings its breakthrough diagnostic testing for Alzheimer’s disease to South Korea. The partnership means health care professionals in South Korea now have access to C2N’s PrecivityAD2™ test, which is an innovative blood test intended for use in patients 50 and older with signs or symptoms of mild cog...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group™ (HealthTrust), a leading healthcare performance improvement organization, shaped the national conversation at the 2026 Federation of American Hospitals (FAH) Conference and Business Exposition, held February 23-25 in Las Vegas, Nevada. The annual event brought together more than 1,300 healthcare supply chain leaders representing hospital management companies, health systems, integrated delivery networks (IDNs), group purchasing o...

PARMA, Italy & HOLMES CHAPEL, England--(BUSINESS WIRE)--Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program...

PARMA, Italia & HOLMES CHAPEL, Regno Unito--(BUSINESS WIRE)--Chiesi, azienda biofarmaceutica internazionale orientata alla ricerca e certificata B Corp, e Bespak, azienda attiva nello sviluppo e nella produzione farmaceutica conto terzi (Contract Development and Manufacturing Organization – CDMO), specializzata nei sistemi di inalazione e focalizzata sulla somministrazione di farmaci per via polmonare e nasale, annunciano oggi l’ampliamento della loro storica collaborazione: previsto nel sito B...